Early memory loss or mild cognitive impairment (MCI) is characterized by memory problems that are annoying and frustrating to the person experiencing them but do not significantly affect a person’s ability to function. Current thinking in the field of Alzheimer’s disease research is that we need to identify Alzheimer’s at the very earliest stages even before a person has dementia. Detailed memory testing, PET scans of the brain, analysis of cerebrospinal fluid, and MRIs may help us to identify initial changes in the brain of an individual with very mild memory loss. If we are able to identify these early changes, using our current research medications may prove to be more helpful. If these efforts are successful, we may be able to more effectively treat or even halt the progression of Alzheimer’s disease.
Early detection and research is the hope for stopping Alzheimer’s disease.
Take our brief early memory loss evaluation and please contact us for more information.